Skip to main content

Heamatology summary 14


Chapter 14 in Haematology (chronic myeloid leukaemia) summary         

 

-Chronic myeloid leukaemia is a clonal disorder of a pluripotent steam cell. The disease accounts for around 15 %of leukamias and may occur at anu age.

-All cases of CML have a transloction between chromosomes 9 and 22. This leads to the BCP hene on chrosome 22 and generates the philadelphia chromosome.

-The resulting chimeric BCR-ABL1 gene codes for a fusion protien with tyrosine kinase activity.

-In some patients the phildaelphia examination of tumour cells but the only be detected by FISH or PCR.

-The disease can occur at any age but is most common between the ages of 40 and 60 years.

-The clinical feauters include anaemia bleeding and splenomegaly. There is usually a marked neutrophlia with myelocytes and basophils seen in the blood film.

-Transformation to an accelerated phase or acyte leukaemia may occur.

-Treatement is with tyrosine kinase inhibitors such as imatinib,dasatinib or nilotinib.tumour cells can acquired resistance totreatment and drug therapy is tailpred in response to this.

-Stem cell transplantation can be curative and may also be useful for advanced disease.

-The clinical outlook is now very good and patient can expect long-term control of disease.

-Chronic eosinophilic and neutrophil leukaemia are much rare.

 

From book: Essentail Haematology A.V.HOFFBRAND,P.A.H.MOSS.6EDITION

Comments

Popular posts from this blog

Haematology summary 18

  Chapter 18 in haematology (chroinc lymphoid leukaemias)summary -Chronic lymphocytic leukaemiaes are characterized by the accumulation of mature B or T lymphocytes in the blood. -Individual subtypes are distinguished on the basis of morphology,immunophenotype and cytogenetics. -Chronic lymphocytic leukaemia (CLL,B cell) represents 90% of cases and has a peak incidece between 60 and 80 years of age .There is genetic predisposition to development of the disease. -Most cases are indenified when a routine blood test is performed the patient can develope enlarged lymph nodes ,splenomegaly and hepatomegaly. -Immunosuppression is asignificant problem because of hypogammaglobuilaemia and cellular immune dysfunction. -Anaemia may also develop because of autoimmune haemolysis and bone marrow in filtration. -Diagnosis is usually performed by immuophenotypic analysis of peripheral blood which reveals aclonal population of CD5 + ,CD23 + B cells. -The best guide

Haematology summary 19

Chapter 19 in haematology (Hodgkin lymphoma)summary -Lymphoma are a group of diseases caused by malignant lymphocytes that accumulation in lymph nodes and cause lymphoadenopathy. -The major subdivision of lymphomas ia into hodgkin and this is based on the presence of Reed-strenberg cells in hodgkin lymphoma. -Reed-strenberg cells are neoplastic B cells but most cells i the lymph node are reactive inflammatory cells. -The usual clinical presentation is with painless asymmetrical lymphadenopathy- most commonly in the neck. -Constitutional symptoms of fever,weight loss and sweating are prominent in patients with widespresd disease. -Blood tests may show anaemia, neutophilia and rasied erythrocyte sedmentation rate (ESR) or lactic dehydrogenase (LDH). -Diagnosis is made by histological examination of an excised lymph node and there are four subtype of disease . -Staging of the disease is important for determining treatment and prognosis history, examiantion

Haematology summary 17

Chapter 17 in haematology (Acute lymphoblastic leukaemia)summary -Acute lymphoblastic leukaemia (ALL) is casued by an accumulation of lymphoblasts in the bone marrow. It isthe most common malignant disease of clidhood-75% of cases occur before the age of 6 years. Eighlty-five per cent of cases are of B-cell lineage with the rest being of T-cell lineage. -The first genetic mutation ocuurs in amy cases in utero , with a secondary genetic event occuring later inclidhood,possibly as a reaction to an infection. -The clinical presentation is with the features of bone marrow failure (anaemia,infection and bleeding) together with symptoms of tissue infiltration by tumour cells, leading to bone pain or swollen lymph nodes. -Diagnosis is by examination of blood and bone marrow.important tests include microscopic examination of the tumour cells, immunophenotyping and genetic analysis. -ALL is subclassified according to the underlying genetic defect and a wide varity of genet